Sept 28 (Reuters) – Summit Therapeutics said on Monday that British drugmaker AstraZeneca would invest $2 billion in the company and collaborate on a series of studies testing their cancer treatments
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
Yankees, Red Sox tab young fireballers Cam Schlittler, Payton Tolle for Game 1
NEW YORK -- While Cam Schlittler's first full season with the New York Yankees was…
AMD to buy Fei-Fei Li's World Labs in $8.2 billion bet on 'physical AI'
Sept 28 (Reuters) - Advanced Micro Devices said on Monday it would acquire Fei-Fei Li's…
Pentagon awards RTX's Raytheon $20.7 billion contract for AMRAAM missiles amid stockpile concerns
(Refiles story to remove errant text in headline, with no changes to the body of…
